Alzamend Neuro Inc. (NASDAQ: ALZN) Stock Jumped 9.57% Over A Month – Is There Any Hope Of A Gain? – Marketing Sentinel
Home  »  Business   »  Alzamend Neuro Inc. (NASDAQ: ALZN) Stock Jumped 9....

Alzamend Neuro Inc. (NASDAQ: ALZN) Stock Jumped 9.57% Over A Month – Is There Any Hope Of A Gain?

During the last session, Alzamend Neuro Inc. (NASDAQ:ALZN)’s traded shares were 1.78 million. At the end of the trading day, the stock’s price was $1.01, reflecting an intraday gain of 10.38% or $0.09. The 52-week high for the ALZN share is $4.54, that puts it down -349.5 from that peak though still a striking 20.79% gain since the share price plummeted to a 52-week low of $0.80. The company’s market capitalization is $94.98M, and the average intraday trading volume over the past 10 days was 0.18 million shares, and the average trade volume was 342.28K shares over the past three months.

Alzamend Neuro Inc. (NASDAQ:ALZN) trade information

Alzamend Neuro Inc. (ALZN) registered a 10.38% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.38% in intraday trading to $1.01 this Thursday, 08/04/22, hitting a weekly high. The stock’s 5-day price performance is 13.87%, and it has moved by 9.57% in 30 days. Based on these gigs, the overall price performance for the year is -76.78%. The short interest in Alzamend Neuro Inc. (NASDAQ:ALZN) is 1.17 million shares and it means that shorts have 5.66 day(s) to cover.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


While earnings are projected to return -133.50% in 2022.

ALZN Dividends

Alzamend Neuro Inc. is due to release its next quarterly earnings in September. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Alzamend Neuro Inc. (NASDAQ:ALZN)’s Major holders

Alzamend Neuro Inc. insiders own 50.51% of total outstanding shares while institutional holders control 3.48%, with the float percentage being 7.03%. Truist Financial Corp is the largest shareholder of the company, while 25 institutions own stock in it. As of Jun 29, 2022, the company held over 2.31 million shares (or 2.42% of all shares), a total value of $2.0 million in shares.

The next largest institutional holding, with 0.25 million shares, is of RFG Advisory, LLC’s that is approximately 0.26% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $0.31 million.

Also, the Mutual Funds coming in first place with the largest holdings of Alzamend Neuro Inc. (ALZN) shares are Fidelity NASDAQ Composite Index Fund and USAA Mutual Fd Tr-Extended Market Index Fd. Data provided on May 30, 2022 indicates that Fidelity NASDAQ Composite Index Fund owns about 40587.0 shares. This amounts to just over 0.04 percent of the company’s overall shares, with a $38212.0 market value. The same data shows that the other fund manager holds slightly less at 7152.0, or about 0.01% of the stock, which is worth about $8796.0.

Leave a Comment

Your email address will not be published.

On Key

Related Posts